Cargando…
Adhesión real al dimetilfumarato en pacientes con esclerosis múltiple remitente-recurrente
INTRODUCTION. Multiple sclerosis is a chronic neurological disease with numerous disease-modifying treatments available, including dimethyl fumarate (DMF), a first-line therapy for relapsing-remitting multiple sclerosis. Although rates of discontinuation of DMF are generally low in clinical trials,...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Viguera Editores (Evidenze Group)
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478096/ https://www.ncbi.nlm.nih.gov/pubmed/36683265 http://dx.doi.org/10.33588/rn.76S01.2022296 |